# Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds

> **NCT07223892** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Bardia Anvar** · enrollment: 600 (estimated)

## Conditions studied

- Chronic Wounds
- Venous Leg Ulcers (VLUs)
- Diabetic Foot Ulcers (DFUs)
- Arterial Ulcers
- Pressure Ulcers
- Burn Wounds
- Trauma Wounds
- Surgical Wounds

## Interventions

- **BIOLOGICAL:** Amniotic Tissue Allograft

## Key facts

- **NCT ID:** NCT07223892
- **Lead sponsor:** Bardia Anvar
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2028-01
- **Final completion:** 2028-03
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07223892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07223892, "Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07223892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*